Back to Search Start Over

Monoallelic loss-of-function BMP2 variants result in BMP2-related skeletal dysplasia spectrum.

Authors :
Priestley JRC
Deshwar AR
Murthy H
D'Agostino MD
Dupuis L
Gangaram B
Gray C
Jobling R
Pannia E
Platzer K
Prescott K
Redman M
Rippert AL
Rosenfeld JA
Scott DA
Wang YW
Schmederer Z
Dalal A
Sarma AS
Skraban C
Dowling JJ
Mendoza-Londono R
Slavotinek A
Bhoj EJ
Source :
Genetics in medicine : official journal of the American College of Medical Genetics [Genet Med] 2023 Aug; Vol. 25 (8), pp. 100863. Date of Electronic Publication: 2023 Apr 28.
Publication Year :
2023

Abstract

Purpose: Bone morphogenic proteins (BMPs) regulate gene expression that is related to many critical developmental processes, including osteogenesis for which they are named. In addition, BMP2 is widely expressed in cells of mesenchymal origin, including bone, cartilage, skeletal and cardiac muscle, and adipose tissue. It also participates in neurodevelopment by inducing differentiation of neural stem cells. In humans, BMP2 variants result in a multiple congenital anomaly syndrome through a haploinsufficiency mechanism. We sought to expand the phenotypic spectrum and highlight phenotypes of patients harboring monoallelic missense variants in BMP2.<br />Methods: We used retrospective chart review to examine phenotypes from an international cohort of 18 individuals and compared these with published cases. Patient-derived missense variants were modeled in zebrafish to examine their effect on the ability of bmp2b to promote embryonic ventralization.<br />Results: The presented cases recapitulated existing descriptions of BMP2-related disorders, including craniofacial, cardiac, and skeletal anomalies and exhibit a wide phenotypic spectrum. We also identified patients with neural tube defects, structural brain anomalies, and endocrinopathies. Missense variants modeled in zebrafish resulted in loss of protein function.<br />Conclusion: We use this expansion of reported phenotypes to suggest multidisciplinary medical monitoring and management of patients with BMP2-related skeletal dysplasia spectrum.<br />Competing Interests: Conflict of Interest Daryl A. Scott is funded by the National Institutes of Health. Jill A. Rosenfeld and Daryl A. Scott are employed by Baylor College of Medicine. The Department of Molecular and Human Genetics at Baylor College of Medicine receives revenue from clinical genetic testing completed at Baylor Genetics Laboratories. All other authors declare no conflicts of interest.<br /> (Copyright © 2023 American College of Medical Genetics and Genomics. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1530-0366
Volume :
25
Issue :
8
Database :
MEDLINE
Journal :
Genetics in medicine : official journal of the American College of Medical Genetics
Publication Type :
Academic Journal
Accession number :
37125634
Full Text :
https://doi.org/10.1016/j.gim.2023.100863